Advancing Rare Disease Treatment and Care with Takeda’s Dr. Mike Denne

In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke with Mike Denne, PharmD, Vice President of US Medical Affairs for Rare Disease and Plasma Derived Therapies at Takeda, to discuss the company’s approach to advancing patient care in the area of rare diseases through medical innovation and collaboration. With over 15 years of leadership experience in medical affairs, Dr. Denne shares his insights on building effective and successful medical teams, including supporting healthcare providers and improving access to therapies for rare disease communities. His experience in the field spans senior leadership of multiple therapeutic areas, product launch, building and leading field medical teams and medical operations. Dr. Denne is passionate about advancing science and education, particularly in diseases where efforts are incrementally impactful for healthcare providers, patients and caregivers who are impacted by them. Tune in to hear how Takeda’s US medical affairs team is helping shape the future of rare disease treatment innovation, access, education and patient engagement. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured